Experts to consider Pfizer’s India application this week

“The matter has been referred to the Subject Expert Committee (SEC), the panel that advises the Drug Controller General of India on new drugs and vaccine approvals,” a senior government official told ET.“The matter has been referred to the Subject Expert Committee (SEC), the panel that advises the Drug Controller General of India on new drugs and vaccine approvals,” a senior government official told ET.Read More

Leave a Reply

Your email address will not be published.